Pancreatic Cancer Action Network News

Home Research For Researchers Research Digest Pancreatic Cancer Action Network News

Highlights of organizational news and research and clinical initiatives.

Check out the Latest Pancreatic Cancer News and Stories from Our Live Newsfeed

New Report Highlights Pancreatic Cancer Prevalence
ACS Cancer Facts & Figures 2018
The American Cancer Society (ACS) released its 2018 Cancer Facts & Figures, an annual report that analyzes cancer statistics and trends and provides predictions for the coming year. The report estimates that 55,440 Americans will be diagnosed with pancreatic cancer this year and that 44,330 will die from the disease.

Largest Gift in PanCAN History Is a Powerful Testament to Donor’s Commitment to Innovation, Impact
An unprecedented $25 million gift has been made to the Pancreatic Cancer Action Network (PanCAN) to honor Skip Viragh’s memory and to support the organization’s goal to change the paradigm for how pancreatic cancer patients are diagnosed and treated and, in turn, dramatically improve outcomes.

Progress Begins Here – Announcing the 2017 Research Grantees
2017 Research Grant Recipients
We are thrilled to announce our 2017 research grants recipients. In collaboration with generous donors, the Pancreatic Cancer Action Network (PanCAN) is investing an estimated $4.9 million in vital pancreatic cancer research through its competitive peer-reviewed 2017 Research Grants Program – including 17 grants to 21 researchers at 12 institutions across the country.

Cancer Progress Spotlighted in the News
In early June, nearly 40,000 clinical oncologists, cancer researchers and other healthcare and industry professionals convened in Chicago for the American Society of Clinical Oncology (ASCO) Annual Meeting – the world’s largest clinical oncology meeting. On June 16, an article was published in Parade that highlights celebration-worthy announcements from this year’s ASCO meeting.

Hundreds of ‘Purple People’ Step Up, Stand Tall, Act Boldly on Capitol Hill
Our nation’s capital was covered in purple on Tuesday, June 20, on the 10th anniversary of National Pancreatic Cancer Advocacy Day. That’s because more than 650 passionate advocates, including more than 100 pancreatic cancer survivors, were on Capitol Hill to urge their members of Congress to make cancer research a national priority. All 50 states were represented, and thousands more from every state called their senators and representative to echo that same message. Take a look at a few highlights from the historic event.

U.S. Congressional Leaders Wage Hope Together to Support Pancreatic Cancer Research
On June 20, congressional leaders came together with bipartisan support for cancer research during the Pancreatic Cancer Action Network’s 10th annual Advocacy Day in Washington D.C.

Medscape Highlights Pancreatic Cancer and Precision PromiseSM in Recent Feature
Medscape published a feature story detailing the science behind pancreatic cancer. The article recounts the devastating statistics of the disease and highlights the advancements being made despite many challenges. At the heart of the article is PanCAN’s revolutionary Precision PromiseSM initiative that is bringing together integral members of the pancreatic cancer community to accelerate research progress for the disease.

Why a Pancreatic Cancer Call Center?
A recent NPR piece highlighted an important topic: cancer call centers. Patients diagnosed with cancer need a lot of information and have many decisions ahead of them. Call centers, like the one featured in the piece and the Pancreatic Cancer Action Network’s Patient Central, provide patients and their families a place to have their questions answered outside the doctor’s office.

PanCAN Featured in the Harvard Business Review
We were featured in the Harvard Business Review for our role in the novel HBS Kraft PM Accelerator initiative. The Accelerator’s mission is to speed medical breakthroughs in precision medicine, the process by which genomic information and other unique characteristics of a person’s disease are used to predict which treatments will be most effective. Four paths have been identified toward Acceleration across all cancers: direct-to-patient, data and analytics, rational clinical trial design, and investment/venture capital.

Clinical Trial Finder
The Clinical Trial Finder saves you time and energy by helping you quickly and easily find the most current pancreatic cancer clinical trials information. By registering for an account, you will have access to the most up-to-date and comprehensive database of pancreatic cancer clinical trials in the United States. Our online tool allows you to perform a patient-specific search to locate available trials based on your patients’ needs or a general search to understand the current clinical trials landscape to inform research or trial design.

Know Your Tumor®
Powerful Knowledge. Personal Treatment.®
Our Know Your Tumor service is an IRB-approved protocol that provides you and your pancreatic cancer patients with a molecular profiling report of their tumor, which includes personalized treatment options – including standard treatments, off-label treatments and available clinical trials. Treatment options are determined after findings of the molecular reports are interpreted by an expert panel, providing valuable insight to support your treatment decisions.

Patient Registry
The Patient Registry is a global online database created to look for patterns in treatments, side effect management and diagnostics that will lead to improved treatment options and outcomes for patients. Whether you have been diagnosed with pancreatic cancer or have provided care for someone with pancreatic cancer, your contributions are meaningful. By joining our quickly growing community and sharing your experiences, you’re giving researchers access to crucial data that will help make discoveries. Together, we will move pancreatic cancer research forward.

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.






Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved.


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision PromiseSM and Demand Better For Patients. For Survival.SM are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.